NCT01306227View on ClinicalTrials.gov

L-Thyroxine Supplementation for Preterm Newborns Less Than 32 Weeks of Gestation With Hypothyroxinemia

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 1, 2006

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2017

Conditions
Hypothyroxinemia
Interventions
DRUG

L-Thyroxine

Treatment with L-Thyroxine:7,5 µg/kg/day. Oral treatment (one drop =5µg) in the morning, once a day.

DRUG

water

Oral treatment with water. Equal number of drop of water as compared with the treatment arm (according to the body weight of the newborn) in the morning, once a day.

Trial Locations (3)

14033

Caen University Hospital, Caen

62307

Lens Hospital, Lens

80054

Amiens University Hospital, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT01306227 - L-Thyroxine Supplementation for Preterm Newborns Less Than 32 Weeks of Gestation With Hypothyroxinemia | Biotech Hunter | Biotech Hunter